{"DataElement":{"publicId":"7710844","version":"1","preferredName":"Head and Neck Cutaneous Squamous Cell Carcinoma Pathologic Stage","preferredDefinition":"Stage group based on the combination of T, N, and M categories and relevant prognostic factors for head and neck cutaneous squamous cell carcinoma.","longName":"7640057v1.0:7652632v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7640057","version":"1","preferredName":"Head and Neck Cutaneous Squamous Cell Carcinoma Stage","preferredDefinition":"For oncology, an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas._A term that refers to the staging of cutaneous squamous cell carcinoma of the head and neck according to the American Joint Committee on Cancer, 8th edition.","longName":"3743524v1.0:7716494v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"3743524","version":"1","preferredName":"Head and Neck","preferredDefinition":"For oncology, area of the body generally construed to comprise base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.","longName":"C12418","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Head and Neck","conceptCode":"C12418","definition":"For oncology, an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DBD62673-2E2C-C572-E040-BB89AD433094","latestVersionIndicator":"Yes","beginDate":"2013-05-03","endDate":null,"createdBy":"PATELV","dateCreated":"2013-05-03","modifiedBy":"ONEDATA","dateModified":"2013-05-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7716494","version":"1","preferredName":"Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage","preferredDefinition":"A term that refers to the staging of cutaneous squamous cell carcinoma of the head and neck according to the American Joint Committee on Cancer, 8th edition.","longName":"C133253","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage","conceptCode":"C133253","definition":"A term that refers to the staging of cutaneous squamous cell carcinoma of the head and neck according to the American Joint Committee on Cancer, 8th edition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C627E621-7E27-06FE-E053-4EBD850A5199","latestVersionIndicator":"Yes","beginDate":"2021-07-02","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-07-02","modifiedBy":"ONEDATA","dateModified":"2021-07-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"C093BEFD-7F40-1945-E053-4EBD850A2CE2","latestVersionIndicator":"Yes","beginDate":"2021-04-22","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-04-22","modifiedBy":"KNABLEJ","dateModified":"2021-07-02","changeDescription":"4/22/21 jk created for CPTAC HNSCC Baseline CRF - generalized AJCC level.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7652632","version":"1","preferredName":"Head and Neck Pathologic Stage","preferredDefinition":"For oncology, an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas._Caused by or altered by or manifesting disease or pathology._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"7652632v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage IV","valueDescription":"Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","ValueMeaning":{"publicId":"7652637","version":"1","preferredName":"Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","longName":"7652637","preferredDefinition":"Stage IV includes: (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (Any T, N3, M0); (T4, Any N, M0); (Any T, Any N, M1). T1: Tumor smaller than 2 cm in greatest dimension. T2: Tumor 2 cm or larger, but smaller than 4 cm in greatest dimension. T3: Tumor 4 cm or larger in greatest dimension or minor bone erosion or perineural invasion or deep invasion. Deep invasion is defined as invasion beyond the subcutaneous fat or larger than 6 mm; perineural invasion for T3 classification is defined as tumor cells within the nerve sheath of a nerve lying deeper than the dermis or measuring 0.1 mm or larger in caliber, or presenting with clinical or radiographic involvement of named nerves without skull base invasion or transgression. T4: Tumor with gross cortical bone/marrow, skull base invasion and/or skull base foramen invasion. N2: Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(+); or metastasis in a single ipsilateral lymph node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(-); or metastases in multiple ipsilateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-); or metastases in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-).  N3: Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(-); or metastasis in a single ipsilateral lymph node larger than 3 cm in greatest dimension and ENE(+); or metastases in multiple ipsilateral, contralateral, or bilateral lymph nodes, any with ENE(+). M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","conceptCode":"C133259","definition":"Stage IV includes: (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (Any T, N3, M0); (T4, Any N, M0); (Any T, Any N, M1). T1: Tumor smaller than 2 cm in greatest dimension. T2: Tumor 2 cm or larger, but smaller than 4 cm in greatest dimension. T3: Tumor 4 cm or larger in greatest dimension or minor bone erosion or perineural invasion or deep invasion. Deep invasion is defined as invasion beyond the subcutaneous fat or larger than 6 mm; perineural invasion for T3 classification is defined as tumor cells within the nerve sheath of a nerve lying deeper than the dermis or measuring 0.1 mm or larger in caliber, or presenting with clinical or radiographic involvement of named nerves without skull base invasion or transgression. T4: Tumor with gross cortical bone/marrow, skull base invasion and/or skull base foramen invasion. N2: Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(+); or metastasis in a single ipsilateral lymph node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(-); or metastases in multiple ipsilateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-); or metastases in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-).  N3: Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(-); or metastasis in a single ipsilateral lymph node larger than 3 cm in greatest dimension and ENE(+); or metastases in multiple ipsilateral, contralateral, or bilateral lymph nodes, any with ENE(+). M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1BF4166-1611-2EBF-E053-4EBD850A39D0","latestVersionIndicator":"Yes","beginDate":"2021-05-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-07","modifiedBy":"ONEDATA","dateModified":"2021-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BF4166-162A-2EBF-E053-4EBD850A39D0","beginDate":"2021-05-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-07","modifiedBy":"ONEDATA","dateModified":"2021-05-07","deletedIndicator":"No"},{"value":"Stage III","valueDescription":"Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","ValueMeaning":{"publicId":"7652639","version":"1","preferredName":"Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","longName":"7652639","preferredDefinition":"Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor 4 cm or larger in greatest dimension or minor bone erosion or perineural invasion or deep invasion. Deep invasion is defined as invasion beyond the subcutaneous fat or larger than 6 mm; perineural invasion for T3 classification is defined as tumor cells within the nerve sheath of a nerve lying deeper than the dermis or measuring 0.1 mm or larger in caliber, or presenting with clinical or radiographic involvement of named nerves without skull base invasion or transgression. T1: Tumor smaller than 2 cm in greatest dimension.  T2: Tumor 2 cm or larger, but smaller than 4 cm in greatest dimension. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(-). M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","conceptCode":"C133258","definition":"Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor 4 cm or larger in greatest dimension or minor bone erosion or perineural invasion or deep invasion. Deep invasion is defined as invasion beyond the subcutaneous fat or larger than 6 mm; perineural invasion for T3 classification is defined as tumor cells within the nerve sheath of a nerve lying deeper than the dermis or measuring 0.1 mm or larger in caliber, or presenting with clinical or radiographic involvement of named nerves without skull base invasion or transgression. T1: Tumor smaller than 2 cm in greatest dimension.  T2: Tumor 2 cm or larger, but smaller than 4 cm in greatest dimension. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(-). M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1BF4166-1637-2EBF-E053-4EBD850A39D0","latestVersionIndicator":"Yes","beginDate":"2021-05-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-07","modifiedBy":"ONEDATA","dateModified":"2021-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BF4166-1650-2EBF-E053-4EBD850A39D0","beginDate":"2021-05-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-07","modifiedBy":"ONEDATA","dateModified":"2021-05-07","deletedIndicator":"No"},{"value":"Stage II","valueDescription":"Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","ValueMeaning":{"publicId":"7652641","version":"1","preferredName":"Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","longName":"7652641","preferredDefinition":"Stage II includes: T2, N0, M0. T2: Tumor 2 cm or larger, but smaller than 4 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","conceptCode":"C133257","definition":"Stage II includes: T2, N0, M0. T2: Tumor 2 cm or larger, but smaller than 4 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1BF4166-165D-2EBF-E053-4EBD850A39D0","latestVersionIndicator":"Yes","beginDate":"2021-05-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-07","modifiedBy":"ONEDATA","dateModified":"2021-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BF4166-1676-2EBF-E053-4EBD850A39D0","beginDate":"2021-05-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-07","modifiedBy":"ONEDATA","dateModified":"2021-05-07","deletedIndicator":"No"},{"value":"Stage I","valueDescription":"Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","ValueMeaning":{"publicId":"7711329","version":"1","preferredName":"Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","longName":"7711329","preferredDefinition":"Stage I includes: T1, N0, M0. T1: Tumor smaller than 2 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","conceptCode":"C133256","definition":"Stage I includes: T1, N0, M0. T1: Tumor smaller than 2 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C57654EE-42CD-7FB9-E053-4EBD850AD954","latestVersionIndicator":"Yes","beginDate":"2021-06-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-06-23","modifiedBy":"ONEDATA","dateModified":"2021-06-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C57654EE-42E6-7FB9-E053-4EBD850AD954","beginDate":"2021-06-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-06-23","modifiedBy":"ONEDATA","dateModified":"2021-06-23","deletedIndicator":"No"},{"value":"Stage IVA","valueDescription":"HNSCC Stage IVA","ValueMeaning":{"publicId":"7716217","version":"1","preferredName":"HNSCC Stage IVA","longName":"7716217v1.00","preferredDefinition":"See the CPTAC Stage IVA coding reference document for criteria.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C60053FC-E05F-7266-E053-4EBD850A90D3","latestVersionIndicator":"Yes","beginDate":"2021-06-30","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-06-30","modifiedBy":"COLBERTM","dateModified":"2022-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C60053FC-E078-7266-E053-4EBD850A90D3","beginDate":"2021-06-30","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-06-30","modifiedBy":"ONEDATA","dateModified":"2021-06-30","deletedIndicator":"No"},{"value":"Stage IVC","valueDescription":"HNSCC Stage IVC","ValueMeaning":{"publicId":"7716239","version":"1","preferredName":"HNSCC Stage IVC","longName":"7716239v1.00","preferredDefinition":"See the CPTAC Stage IVC coding reference document for criteria.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6009736-2490-1FB7-E053-4EBD850A3F6E","latestVersionIndicator":"Yes","beginDate":"2021-06-30","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-06-30","modifiedBy":"COLBERTM","dateModified":"2022-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6009736-24A9-1FB7-E053-4EBD850A3F6E","beginDate":"2021-06-30","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-06-30","modifiedBy":"ONEDATA","dateModified":"2021-06-30","deletedIndicator":"No"},{"value":"Stage IVB","valueDescription":"HNSCC Stage IVB","ValueMeaning":{"publicId":"7716240","version":"1","preferredName":"HNSCC Stage IVB","longName":"7716240v1.00","preferredDefinition":"See the CPTAC Stage IVB coding reference document for criteria.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6009736-24B3-1FB7-E053-4EBD850A3F6E","latestVersionIndicator":"Yes","beginDate":"2021-06-30","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-06-30","modifiedBy":"COLBERTM","dateModified":"2022-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6009736-24CC-1FB7-E053-4EBD850A3F6E","beginDate":"2021-06-30","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-06-30","modifiedBy":"ONEDATA","dateModified":"2021-06-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435032","version":"1","preferredName":"Property or Attribute","preferredDefinition":"The distinguishing qualities or prominent aspect of a person, object, action, process, or substance.","longName":"C20189","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-8321-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7716495","version":"1","preferredName":"Head and Neck Pathologic Stage","preferredDefinition":"For oncology, an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.:Caused by or altered by or manifesting disease or pathology.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C12418:C25610:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Head and Neck","conceptCode":"C12418","definition":"For oncology, an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6285DB1-25E8-72D4-E053-4EBD850AD2E4","latestVersionIndicator":"Yes","beginDate":"2021-07-02","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-07-02","modifiedBy":"ONEDATA","dateModified":"2021-07-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"C1BF4166-158D-2EBF-E053-4EBD850A39D0","latestVersionIndicator":"Yes","beginDate":"2021-05-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-07","modifiedBy":"COLBERTM","dateModified":"2022-08-22","changeDescription":"7/2/21 jk CPTAC specific; upd to use C12418.  6/23/21 jk updated semantics; pending terms for IVA, IVB, and IVC PVs.  5/7/21 ls missing pv cui ls","administrativeNotes":"8/22/22 Updated definition and ref doc for IVA, IVB, IVC PVs, and RS to Application per jk. MR;","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"7218867","version":"1","longName":"Head and Neck","context":"OCCPR"},{"publicId":"7634285","version":"1","longName":"HNSCC Baseline","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Tumor Stage (Pathologic)","type":"Preferred Question Text","description":"Tumor Stage (Pathologic)","url":null,"context":"OCCPR"},{"name":"CPTAC-Stage IVA","type":"Coding Instructions","description":"Attached word or pdf document name.  A URL can be added to the source document.","url":null,"context":"OCCPR"},{"name":"CPTAC-Stage IVB","type":"Coding Instructions","description":"Attached word or pdf document name.  A URL can be added to the source document.","url":null,"context":"OCCPR"},{"name":"CPTAC-Stage IVC","type":"Coding Instructions","description":"Attached word or pdf document name.  A URL can be added to the source document.","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"C5764D1B-E76D-79BD-E053-4EBD850A4793","latestVersionIndicator":"Yes","beginDate":"2021-06-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-06-23","modifiedBy":"COLBERTM","dateModified":"2022-08-22","changeDescription":"6/23/21 jk created for CPTAC HNSCC Baseline CRF for CPTAC specific PVs.  Incomplete pending IVA, IVB, and IVC terms.","administrativeNotes":"8/22/22 Updated definition and ref doc for IVA, IVB, IVC PVs, and RS to Application per jk. MR;","unresolvedIssues":null,"deletedIndicator":"No"}}